HEADER TRANSFERASE 15-DEC-11 4ACG
TITLE GSK3B IN COMPLEX WITH INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: GSK-3 BETA, SERINE/THREONINE-PROTEIN KINASE GSK3B,;
COMPND 5 EC: 2.7.11.1, 2.7.11.26;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI;
SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PFASTBAC HTB
KEYWDS TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.XUE,M.ORMO
REVDAT 4 08-MAY-24 4ACG 1 REMARK
REVDAT 3 14-FEB-18 4ACG 1 JRNL
REVDAT 2 21-NOV-12 4ACG 1 JRNL
REVDAT 1 16-MAY-12 4ACG 0
JRNL AUTH S.BERG,M.BERGH,S.HELLBERG,K.HOGDIN,Y.LO-ALFREDSSON,
JRNL AUTH 2 P.SODERMAN,S.VON BERG,T.WEIGELT,M.ORMO,Y.XUE,J.TUCKER,
JRNL AUTH 3 J.NEELISSEN,E.JERNING,Y.NILSSON,R.BHAT
JRNL TITL DISCOVERY OF NOVEL POTENT AND HIGHLY SELECTIVE GLYCOGEN
JRNL TITL 2 SYNTHASE KINASE-3 BETA (GSK3 BETA ) INHIBITORS FOR
JRNL TITL 3 ALZHEIMER'S DISEASE: DESIGN, SYNTHESIS, AND CHARACTERIZATION
JRNL TITL 4 OF PYRAZINES.
JRNL REF J. MED. CHEM. V. 55 9107 2012
JRNL REFN ISSN 1520-4804
JRNL PMID 22489897
JRNL DOI 10.1021/JM201724M
REMARK 2
REMARK 2 RESOLUTION. 2.60 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.1
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.97
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1
REMARK 3 NUMBER OF REFLECTIONS : 37947
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.177
REMARK 3 R VALUE (WORKING SET) : 0.175
REMARK 3 FREE R VALUE : 0.225
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.010
REMARK 3 FREE R VALUE TEST SET COUNT : 1520
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 19
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.67
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.06
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2752
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2302
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2641
REMARK 3 BIN R VALUE (WORKING SET) : 0.2261
REMARK 3 BIN FREE R VALUE : 0.3220
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.03
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 111
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 5610
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 76
REMARK 3 SOLVENT ATOMS : 485
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 54.63
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.24
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -13.96510
REMARK 3 B22 (A**2) : -1.15270
REMARK 3 B33 (A**2) : 15.11780
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.291
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.340
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.240
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.310
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.236
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 5836 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 7946 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1986 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 126 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 840 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 5836 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 750 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 6798 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.14
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.94
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.49
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP.
REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY
REMARK 4
REMARK 4 4ACG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-DEC-11.
REMARK 100 THE DEPOSITION ID IS D_1290050715.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : 173
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38081
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 6.200
REMARK 200 R MERGE (I) : 0.12000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75
REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2
REMARK 200 DATA REDUNDANCY IN SHELL : 3.90
REMARK 200 R MERGE FOR SHELL (I) : 0.54000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NONE
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 57.99
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.99
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.98800
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.73050
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.94050
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.73050
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.98800
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.94050
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2560 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 31770 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.1 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A -44
REMARK 465 SER A -43
REMARK 465 TYR A -42
REMARK 465 TYR A -41
REMARK 465 HIS A -40
REMARK 465 HIS A -39
REMARK 465 HIS A -38
REMARK 465 HIS A -37
REMARK 465 HIS A -36
REMARK 465 HIS A -35
REMARK 465 ASP A -34
REMARK 465 TYR A -33
REMARK 465 ASP A -32
REMARK 465 ILE A -31
REMARK 465 PRO A -30
REMARK 465 THR A -29
REMARK 465 THR A -28
REMARK 465 GLU A -27
REMARK 465 ASN A -26
REMARK 465 LEU A -25
REMARK 465 TYR A -24
REMARK 465 PHE A -23
REMARK 465 GLN A -22
REMARK 465 GLY A -21
REMARK 465 ALA A -20
REMARK 465 MET A -19
REMARK 465 GLY A -18
REMARK 465 SER A -17
REMARK 465 SER A -16
REMARK 465 HIS A -15
REMARK 465 HIS A -14
REMARK 465 HIS A -13
REMARK 465 HIS A -12
REMARK 465 HIS A -11
REMARK 465 HIS A -10
REMARK 465 SER A -9
REMARK 465 SER A -8
REMARK 465 GLY A -7
REMARK 465 LEU A -6
REMARK 465 VAL A -5
REMARK 465 PRO A -4
REMARK 465 ARG A -3
REMARK 465 GLY A -2
REMARK 465 SER A -1
REMARK 465 HIS A 0
REMARK 465 MET A 1
REMARK 465 SER A 2
REMARK 465 GLY A 3
REMARK 465 ARG A 4
REMARK 465 PRO A 5
REMARK 465 ARG A 6
REMARK 465 THR A 7
REMARK 465 THR A 8
REMARK 465 SER A 9
REMARK 465 PHE A 10
REMARK 465 ALA A 11
REMARK 465 GLU A 12
REMARK 465 SER A 13
REMARK 465 CYS A 14
REMARK 465 LYS A 15
REMARK 465 PRO A 16
REMARK 465 VAL A 17
REMARK 465 GLN A 18
REMARK 465 GLN A 19
REMARK 465 PRO A 20
REMARK 465 SER A 21
REMARK 465 ALA A 22
REMARK 465 PHE A 23
REMARK 465 GLY A 24
REMARK 465 SER A 25
REMARK 465 MET A 26
REMARK 465 LYS A 27
REMARK 465 VAL A 28
REMARK 465 SER A 29
REMARK 465 ARG A 30
REMARK 465 ASP A 31
REMARK 465 LYS A 32
REMARK 465 ASP A 33
REMARK 465 GLY A 34
REMARK 465 ALA A 386
REMARK 465 ALA A 387
REMARK 465 ALA A 388
REMARK 465 SER A 389
REMARK 465 THR A 390
REMARK 465 PRO A 391
REMARK 465 THR A 392
REMARK 465 ASN A 393
REMARK 465 ALA A 394
REMARK 465 THR A 395
REMARK 465 ALA A 396
REMARK 465 ALA A 397
REMARK 465 SER A 398
REMARK 465 ASP A 399
REMARK 465 ALA A 400
REMARK 465 ASN A 401
REMARK 465 THR A 402
REMARK 465 GLY A 403
REMARK 465 ASP A 404
REMARK 465 ARG A 405
REMARK 465 GLY A 406
REMARK 465 GLN A 407
REMARK 465 THR A 408
REMARK 465 ASN A 409
REMARK 465 ASN A 410
REMARK 465 ALA A 411
REMARK 465 ALA A 412
REMARK 465 SER A 413
REMARK 465 ALA A 414
REMARK 465 SER A 415
REMARK 465 ALA A 416
REMARK 465 SER A 417
REMARK 465 ASN A 418
REMARK 465 SER A 419
REMARK 465 THR A 420
REMARK 465 MET B -44
REMARK 465 SER B -43
REMARK 465 TYR B -42
REMARK 465 TYR B -41
REMARK 465 HIS B -40
REMARK 465 HIS B -39
REMARK 465 HIS B -38
REMARK 465 HIS B -37
REMARK 465 HIS B -36
REMARK 465 HIS B -35
REMARK 465 ASP B -34
REMARK 465 TYR B -33
REMARK 465 ASP B -32
REMARK 465 ILE B -31
REMARK 465 PRO B -30
REMARK 465 THR B -29
REMARK 465 THR B -28
REMARK 465 GLU B -27
REMARK 465 ASN B -26
REMARK 465 LEU B -25
REMARK 465 TYR B -24
REMARK 465 PHE B -23
REMARK 465 GLN B -22
REMARK 465 GLY B -21
REMARK 465 ALA B -20
REMARK 465 MET B -19
REMARK 465 GLY B -18
REMARK 465 SER B -17
REMARK 465 SER B -16
REMARK 465 HIS B -15
REMARK 465 HIS B -14
REMARK 465 HIS B -13
REMARK 465 HIS B -12
REMARK 465 HIS B -11
REMARK 465 HIS B -10
REMARK 465 SER B -9
REMARK 465 SER B -8
REMARK 465 GLY B -7
REMARK 465 LEU B -6
REMARK 465 VAL B -5
REMARK 465 PRO B -4
REMARK 465 ARG B -3
REMARK 465 GLY B -2
REMARK 465 SER B -1
REMARK 465 HIS B 0
REMARK 465 MET B 1
REMARK 465 SER B 2
REMARK 465 GLY B 3
REMARK 465 ARG B 4
REMARK 465 PRO B 5
REMARK 465 ARG B 6
REMARK 465 THR B 7
REMARK 465 THR B 8
REMARK 465 SER B 9
REMARK 465 PHE B 10
REMARK 465 ALA B 11
REMARK 465 GLU B 12
REMARK 465 SER B 13
REMARK 465 CYS B 14
REMARK 465 LYS B 15
REMARK 465 PRO B 16
REMARK 465 VAL B 17
REMARK 465 GLN B 18
REMARK 465 GLN B 19
REMARK 465 PRO B 20
REMARK 465 SER B 21
REMARK 465 ALA B 22
REMARK 465 PHE B 23
REMARK 465 GLY B 24
REMARK 465 SER B 25
REMARK 465 MET B 26
REMARK 465 LYS B 27
REMARK 465 VAL B 28
REMARK 465 SER B 29
REMARK 465 ARG B 30
REMARK 465 ASP B 31
REMARK 465 LYS B 32
REMARK 465 ASP B 33
REMARK 465 GLY B 34
REMARK 465 ALA B 386
REMARK 465 ALA B 387
REMARK 465 ALA B 388
REMARK 465 SER B 389
REMARK 465 THR B 390
REMARK 465 PRO B 391
REMARK 465 THR B 392
REMARK 465 ASN B 393
REMARK 465 ALA B 394
REMARK 465 THR B 395
REMARK 465 ALA B 396
REMARK 465 ALA B 397
REMARK 465 SER B 398
REMARK 465 ASP B 399
REMARK 465 ALA B 400
REMARK 465 ASN B 401
REMARK 465 THR B 402
REMARK 465 GLY B 403
REMARK 465 ASP B 404
REMARK 465 ARG B 405
REMARK 465 GLY B 406
REMARK 465 GLN B 407
REMARK 465 THR B 408
REMARK 465 ASN B 409
REMARK 465 ASN B 410
REMARK 465 ALA B 411
REMARK 465 ALA B 412
REMARK 465 SER B 413
REMARK 465 ALA B 414
REMARK 465 SER B 415
REMARK 465 ALA B 416
REMARK 465 SER B 417
REMARK 465 ASN B 418
REMARK 465 SER B 419
REMARK 465 THR B 420
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLN A 385 CA C O CB CG CD OE1
REMARK 470 GLN A 385 NE2
REMARK 470 GLN B 385 CA C O CB CG CD OE1
REMARK 470 GLN B 385 NE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 49 79.89 -69.02
REMARK 500 ASP A 77 -79.68 -57.82
REMARK 500 LYS A 91 -31.40 66.48
REMARK 500 SER A 118 -160.66 -165.52
REMARK 500 GLU A 121 83.67 -152.23
REMARK 500 LYS A 122 -49.87 -144.13
REMARK 500 ASP A 124 -26.14 70.81
REMARK 500 ASP A 181 46.46 -143.54
REMARK 500 ASP A 200 92.50 66.16
REMARK 500 CYS A 218 136.71 82.24
REMARK 500 TYR A 221 -31.68 97.40
REMARK 500 MET A 284 -74.02 -83.70
REMARK 500 PRO A 286 25.24 -77.07
REMARK 500 GLN A 295 81.08 -63.71
REMARK 500 PRO A 357 -178.67 -65.43
REMARK 500 ASN A 370 76.42 -163.46
REMARK 500 LYS B 91 -22.35 64.88
REMARK 500 GLU B 121 -47.59 128.06
REMARK 500 ASP B 181 47.50 -145.04
REMARK 500 ASP B 200 92.34 67.23
REMARK 500 CYS B 218 137.88 83.12
REMARK 500 TYR B 221 -31.78 98.28
REMARK 500 MET B 284 -73.14 -91.43
REMARK 500 GLN B 295 82.00 -62.99
REMARK 500 PRO B 357 -177.85 -66.83
REMARK 500 ASN B 370 76.07 -164.47
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH B2124 DISTANCE = 6.04 ANGSTROMS
REMARK 525 HOH B2258 DISTANCE = 8.33 ANGSTROMS
REMARK 525 HOH B2260 DISTANCE = 6.22 ANGSTROMS
REMARK 525 HOH B2261 DISTANCE = 6.64 ANGSTROMS
REMARK 700
REMARK 700 SHEET
REMARK 700 DETERMINATION METHOD: DSSP
REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS
REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY
REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
REMARK 700 ARE IDENTICAL.
REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS
REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY
REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
REMARK 700 ARE IDENTICAL.
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6LQ A 1385
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6LQ B 1385
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1GNG RELATED DB: PDB
REMARK 900 GLYCOGEN SYNTHASE 3BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE
REMARK 900 RELATED ID: 1H8F RELATED DB: PDB
REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA.
REMARK 900 RELATED ID: 1I09 RELATED DB: PDB
REMARK 900 STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
REMARK 900 RELATED ID: 1J1B RELATED DB: PDB
REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHAMPPNP
REMARK 900 RELATED ID: 1J1C RELATED DB: PDB
REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHADP
REMARK 900 RELATED ID: 1O6K RELATED DB: PDB
REMARK 900 STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3
REMARK 900 PEPTIDE AND AMP-PNP
REMARK 900 RELATED ID: 1O6L RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF
REMARK 900 CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE
REMARK 900 RELATED ID: 1O9U RELATED DB: PDB
REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE
REMARK 900 RELATED ID: 1PYX RELATED DB: PDB
REMARK 900 GSK-3 BETA COMPLEXED WITH AMP-PNP
REMARK 900 RELATED ID: 1Q3D RELATED DB: PDB
REMARK 900 GSK-3 BETA COMPLEXED WITH STAUROSPORINE
REMARK 900 RELATED ID: 1Q3W RELATED DB: PDB
REMARK 900 GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE
REMARK 900 RELATED ID: 1Q41 RELATED DB: PDB
REMARK 900 GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME
REMARK 900 RELATED ID: 1Q4L RELATED DB: PDB
REMARK 900 GSK-3 BETA COMPLEXED WITH INHIBITOR I-5
REMARK 900 RELATED ID: 1Q5K RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 INCOMPLEXED WITH
REMARK 900 INHIBITOR
REMARK 900 RELATED ID: 1R0E RELATED DB: PDB
REMARK 900 GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3- INDOLYL-4-
REMARK 900 ARYLMALEIMIDE INHIBITOR
REMARK 900 RELATED ID: 1UV5 RELATED DB: PDB
REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6- BROMOINDIRUBIN-3'-
REMARK 900 OXIME
REMARK 900 RELATED ID: 2JDO RELATED DB: PDB
REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE -5-
REMARK 900 SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO) ETHYL)AMIDE
REMARK 900 RELATED ID: 2JDR RELATED DB: PDB
REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654
REMARK 900 RELATED ID: 2JLD RELATED DB: PDB
REMARK 900 EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE
REMARK 900 KINASE 3
REMARK 900 RELATED ID: 2UW9 RELATED DB: PDB
REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4- CHLORO-PHENYL)-4-
REMARK 900 (4-(1H-PYRAZOL-4-YL)-PHENYL)- PIPERIDINE
REMARK 900 RELATED ID: 2X37 RELATED DB: PDB
REMARK 900 STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2 ,3-D)PYRIMIDIN-
REMARK 900 4-YL)PIPERIDIN-4-AMINE BOUND TO PKB
REMARK 900 RELATED ID: 2X39 RELATED DB: PDB
REMARK 900 STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H- PYRROLO(2,3-D)
REMARK 900 PYRIMIDIN-4-YL)PIPERIDINE-4- CARBOXAMIDE BOUND TO PKB
REMARK 900 RELATED ID: 2XH5 RELATED DB: PDB
REMARK 900 STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2 ,3-D)PYRIMIDIN-
REMARK 900 4-YL)PIPERIDIN-4-AMINE BOUND TO PKB
REMARK 900 RELATED ID: 3ZRK RELATED DB: PDB
REMARK 900 IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK -3BETA
REMARK 900 INHIBITORS
REMARK 900 RELATED ID: 3ZRL RELATED DB: PDB
REMARK 900 IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK -3BETA
REMARK 900 INHIBITORS
REMARK 900 RELATED ID: 3ZRM RELATED DB: PDB
REMARK 900 IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK -3BETA
REMARK 900 INHIBITORS
REMARK 900 RELATED ID: 4ACC RELATED DB: PDB
REMARK 900 GSK3B IN COMPLEX WITH INHIBITOR
REMARK 900 RELATED ID: 4ACD RELATED DB: PDB
REMARK 900 GSK3B IN COMPLEX WITH INHIBITOR
REMARK 900 RELATED ID: 4ACH RELATED DB: PDB
REMARK 900 GSK3B IN COMPLEX WITH INHIBITOR
DBREF 4ACG A 1 420 UNP P49841 GSK3B_HUMAN 1 420
DBREF 4ACG B 1 420 UNP P49841 GSK3B_HUMAN 1 420
SEQADV 4ACG MET A -44 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER A -43 UNP P49841 EXPRESSION TAG
SEQADV 4ACG TYR A -42 UNP P49841 EXPRESSION TAG
SEQADV 4ACG TYR A -41 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -40 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -39 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -38 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -37 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -36 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -35 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ASP A -34 UNP P49841 EXPRESSION TAG
SEQADV 4ACG TYR A -33 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ASP A -32 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ILE A -31 UNP P49841 EXPRESSION TAG
SEQADV 4ACG PRO A -30 UNP P49841 EXPRESSION TAG
SEQADV 4ACG THR A -29 UNP P49841 EXPRESSION TAG
SEQADV 4ACG THR A -28 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLU A -27 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ASN A -26 UNP P49841 EXPRESSION TAG
SEQADV 4ACG LEU A -25 UNP P49841 EXPRESSION TAG
SEQADV 4ACG TYR A -24 UNP P49841 EXPRESSION TAG
SEQADV 4ACG PHE A -23 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLN A -22 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLY A -21 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ALA A -20 UNP P49841 EXPRESSION TAG
SEQADV 4ACG MET A -19 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLY A -18 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER A -17 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER A -16 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -15 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -14 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -13 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -12 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -11 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A -10 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER A -9 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER A -8 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLY A -7 UNP P49841 EXPRESSION TAG
SEQADV 4ACG LEU A -6 UNP P49841 EXPRESSION TAG
SEQADV 4ACG VAL A -5 UNP P49841 EXPRESSION TAG
SEQADV 4ACG PRO A -4 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ARG A -3 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLY A -2 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER A -1 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS A 0 UNP P49841 EXPRESSION TAG
SEQADV 4ACG MET B -44 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER B -43 UNP P49841 EXPRESSION TAG
SEQADV 4ACG TYR B -42 UNP P49841 EXPRESSION TAG
SEQADV 4ACG TYR B -41 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -40 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -39 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -38 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -37 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -36 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -35 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ASP B -34 UNP P49841 EXPRESSION TAG
SEQADV 4ACG TYR B -33 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ASP B -32 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ILE B -31 UNP P49841 EXPRESSION TAG
SEQADV 4ACG PRO B -30 UNP P49841 EXPRESSION TAG
SEQADV 4ACG THR B -29 UNP P49841 EXPRESSION TAG
SEQADV 4ACG THR B -28 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLU B -27 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ASN B -26 UNP P49841 EXPRESSION TAG
SEQADV 4ACG LEU B -25 UNP P49841 EXPRESSION TAG
SEQADV 4ACG TYR B -24 UNP P49841 EXPRESSION TAG
SEQADV 4ACG PHE B -23 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLN B -22 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLY B -21 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ALA B -20 UNP P49841 EXPRESSION TAG
SEQADV 4ACG MET B -19 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLY B -18 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER B -17 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER B -16 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -15 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -14 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -13 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -12 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -11 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B -10 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER B -9 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER B -8 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLY B -7 UNP P49841 EXPRESSION TAG
SEQADV 4ACG LEU B -6 UNP P49841 EXPRESSION TAG
SEQADV 4ACG VAL B -5 UNP P49841 EXPRESSION TAG
SEQADV 4ACG PRO B -4 UNP P49841 EXPRESSION TAG
SEQADV 4ACG ARG B -3 UNP P49841 EXPRESSION TAG
SEQADV 4ACG GLY B -2 UNP P49841 EXPRESSION TAG
SEQADV 4ACG SER B -1 UNP P49841 EXPRESSION TAG
SEQADV 4ACG HIS B 0 UNP P49841 EXPRESSION TAG
SEQRES 1 A 465 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP
SEQRES 2 A 465 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET
SEQRES 3 A 465 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU
SEQRES 4 A 465 VAL PRO ARG GLY SER HIS MET SER GLY ARG PRO ARG THR
SEQRES 5 A 465 THR SER PHE ALA GLU SER CYS LYS PRO VAL GLN GLN PRO
SEQRES 6 A 465 SER ALA PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP
SEQRES 7 A 465 GLY SER LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN
SEQRES 8 A 465 GLY PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR
SEQRES 9 A 465 LYS VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN
SEQRES 10 A 465 ALA LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS
SEQRES 11 A 465 LYS VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU
SEQRES 12 A 465 GLN ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG
SEQRES 13 A 465 LEU ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP
SEQRES 14 A 465 GLU VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU
SEQRES 15 A 465 THR VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS
SEQRES 16 A 465 GLN THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR
SEQRES 17 A 465 GLN LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY
SEQRES 18 A 465 ILE CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU
SEQRES 19 A 465 ASP PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY
SEQRES 20 A 465 SER ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER
SEQRES 21 A 465 TYR ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE
SEQRES 22 A 465 PHE GLY ALA THR ASP TYR THR SER SER ILE ASP VAL TRP
SEQRES 23 A 465 SER ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN
SEQRES 24 A 465 PRO ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL
SEQRES 25 A 465 GLU ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN
SEQRES 26 A 465 ILE ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE
SEQRES 27 A 465 PRO GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG
SEQRES 28 A 465 PRO ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG
SEQRES 29 A 465 LEU LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU
SEQRES 30 A 465 GLU ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP
SEQRES 31 A 465 PRO ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA
SEQRES 32 A 465 LEU PHE ASN PHE THR THR GLN GLU LEU SER SER ASN PRO
SEQRES 33 A 465 PRO LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE
SEQRES 34 A 465 GLN ALA ALA ALA SER THR PRO THR ASN ALA THR ALA ALA
SEQRES 35 A 465 SER ASP ALA ASN THR GLY ASP ARG GLY GLN THR ASN ASN
SEQRES 36 A 465 ALA ALA SER ALA SER ALA SER ASN SER THR
SEQRES 1 B 465 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP
SEQRES 2 B 465 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET
SEQRES 3 B 465 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU
SEQRES 4 B 465 VAL PRO ARG GLY SER HIS MET SER GLY ARG PRO ARG THR
SEQRES 5 B 465 THR SER PHE ALA GLU SER CYS LYS PRO VAL GLN GLN PRO
SEQRES 6 B 465 SER ALA PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP
SEQRES 7 B 465 GLY SER LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN
SEQRES 8 B 465 GLY PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR
SEQRES 9 B 465 LYS VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN
SEQRES 10 B 465 ALA LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS
SEQRES 11 B 465 LYS VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU
SEQRES 12 B 465 GLN ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG
SEQRES 13 B 465 LEU ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP
SEQRES 14 B 465 GLU VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU
SEQRES 15 B 465 THR VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS
SEQRES 16 B 465 GLN THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR
SEQRES 17 B 465 GLN LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY
SEQRES 18 B 465 ILE CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU
SEQRES 19 B 465 ASP PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY
SEQRES 20 B 465 SER ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER
SEQRES 21 B 465 TYR ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE
SEQRES 22 B 465 PHE GLY ALA THR ASP TYR THR SER SER ILE ASP VAL TRP
SEQRES 23 B 465 SER ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN
SEQRES 24 B 465 PRO ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL
SEQRES 25 B 465 GLU ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN
SEQRES 26 B 465 ILE ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE
SEQRES 27 B 465 PRO GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG
SEQRES 28 B 465 PRO ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG
SEQRES 29 B 465 LEU LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU
SEQRES 30 B 465 GLU ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP
SEQRES 31 B 465 PRO ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA
SEQRES 32 B 465 LEU PHE ASN PHE THR THR GLN GLU LEU SER SER ASN PRO
SEQRES 33 B 465 PRO LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE
SEQRES 34 B 465 GLN ALA ALA ALA SER THR PRO THR ASN ALA THR ALA ALA
SEQRES 35 B 465 SER ASP ALA ASN THR GLY ASP ARG GLY GLN THR ASN ASN
SEQRES 36 B 465 ALA ALA SER ALA SER ALA SER ASN SER THR
HET 6LQ A1385 38
HET 6LQ B1385 38
HETNAM 6LQ 2-AMINO-5-{4-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-
HETNAM 2 6LQ N-[4-(PYRROLIDIN-1-YLMETHYL)PYRIDIN-3-YL]PYRIDINE-3-
HETNAM 3 6LQ CARBOXAMIDE
FORMUL 3 6LQ 2(C27 H33 N7 O3 S)
FORMUL 5 HOH *485(H2 O)
HELIX 1 1 ASN A 95 LYS A 103 1 9
HELIX 2 2 VAL A 139 ALA A 149 1 11
HELIX 3 3 PRO A 154 PHE A 175 1 22
HELIX 4 4 LYS A 183 GLN A 185 5 3
HELIX 5 5 ALA A 224 PHE A 229 1 6
HELIX 6 6 SER A 236 GLY A 253 1 18
HELIX 7 7 SER A 261 GLY A 274 1 14
HELIX 8 8 THR A 277 ASN A 285 1 9
HELIX 9 9 PRO A 300 PHE A 305 1 6
HELIX 10 10 PRO A 310 LEU A 321 1 12
HELIX 11 11 THR A 324 ARG A 328 5 5
HELIX 12 12 THR A 330 ALA A 336 1 7
HELIX 13 13 HIS A 337 ASP A 345 5 9
HELIX 14 14 THR A 363 SER A 368 1 6
HELIX 15 15 ASN A 370 PRO A 372 5 3
HELIX 16 16 LEU A 373 ILE A 378 1 6
HELIX 17 17 PRO A 379 ILE A 384 1 6
HELIX 18 18 ASN B 95 LYS B 103 1 9
HELIX 19 19 VAL B 139 ALA B 149 1 11
HELIX 20 20 PRO B 154 PHE B 175 1 22
HELIX 21 21 LYS B 183 GLN B 185 5 3
HELIX 22 22 ALA B 224 PHE B 229 1 6
HELIX 23 23 SER B 236 GLY B 253 1 18
HELIX 24 24 SER B 261 GLY B 274 1 14
HELIX 25 25 THR B 277 ASN B 285 1 9
HELIX 26 26 PRO B 286 THR B 289 5 4
HELIX 27 27 PRO B 300 PHE B 305 1 6
HELIX 28 28 PRO B 310 LEU B 321 1 12
HELIX 29 29 THR B 324 ARG B 328 5 5
HELIX 30 30 THR B 330 ALA B 336 1 7
HELIX 31 31 HIS B 337 ASP B 345 5 9
HELIX 32 32 THR B 363 SER B 368 1 6
HELIX 33 33 ASN B 370 PRO B 372 5 3
HELIX 34 34 LEU B 373 ILE B 378 1 6
SHEET 1 AA 7 THR A 38 PRO A 44 0
SHEET 2 AA 7 GLN A 52 ASN A 64 -1 O GLN A 52 N ALA A 42
SHEET 3 AA 7 GLY A 68 LEU A 75 -1 O VAL A 70 N ILE A 62
SHEET 4 AA 7 LEU A 81 GLN A 89 -1 O VAL A 82 N ALA A 73
SHEET 5 AA 7 VAL A 126 ASP A 133 -1 O VAL A 126 N GLN A 89
SHEET 6 AA 7 LEU A 112 SER A 118 -1 N ARG A 113 O VAL A 131
SHEET 7 AA 7 THR A 38 PRO A 44 -1 O THR A 43 N PHE A 115
SHEET 1 AB 3 GLU A 137 THR A 138 0
SHEET 2 AB 3 LEU A 187 ASP A 190 -1 O LEU A 189 N GLU A 137
SHEET 3 AB 3 VAL A 195 LEU A 198 -1 O VAL A 195 N ASP A 190
SHEET 1 AC 2 ILE A 177 CYS A 178 0
SHEET 2 AC 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178
SHEET 1 BA 7 THR B 38 PRO B 44 0
SHEET 2 BA 7 GLN B 52 ASN B 64 -1 O GLN B 52 N ALA B 42
SHEET 3 BA 7 VAL B 69 LEU B 75 -1 O VAL B 70 N ILE B 62
SHEET 4 BA 7 LEU B 81 GLN B 89 -1 O VAL B 82 N ALA B 73
SHEET 5 BA 7 VAL B 126 ASP B 133 -1 O VAL B 126 N GLN B 89
SHEET 6 BA 7 LEU B 112 SER B 118 -1 N ARG B 113 O VAL B 131
SHEET 7 BA 7 THR B 38 PRO B 44 -1 O THR B 43 N PHE B 115
SHEET 1 BB 3 GLU B 137 THR B 138 0
SHEET 2 BB 3 LEU B 187 ASP B 190 -1 O LEU B 189 N GLU B 137
SHEET 3 BB 3 VAL B 195 LEU B 198 -1 O VAL B 195 N ASP B 190
SHEET 1 BC 2 ILE B 177 CYS B 178 0
SHEET 2 BC 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178
CISPEP 1 GLU A 121 LYS A 122 0 -1.33
SITE 1 AC1 16 ILE A 62 VAL A 70 ALA A 83 LYS A 85
SITE 2 AC1 16 VAL A 110 LEU A 132 ASP A 133 TYR A 134
SITE 3 AC1 16 VAL A 135 PRO A 136 ARG A 141 GLN A 185
SITE 4 AC1 16 ASN A 186 LEU A 188 CYS A 199 ASP A 200
SITE 1 AC2 16 ILE B 62 ALA B 83 LYS B 85 VAL B 110
SITE 2 AC2 16 LEU B 132 ASP B 133 TYR B 134 VAL B 135
SITE 3 AC2 16 PRO B 136 GLU B 137 ARG B 141 GLN B 185
SITE 4 AC2 16 ASN B 186 LEU B 188 ASP B 200 HOH B2144
CRYST1 81.976 83.881 177.461 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.012199 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011922 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005635 0.00000